The Alzheimer´s Global Summit will take place on September 18-22, 2017 in Lisbon, Portugal at the Champalimaud Foundation with the support of the Queen Sofia Foundation. This key meeting on Alzheimer´s Disease will be built on two main pillars: the Social and Health Care Research (September 18-19), organized by the National Reference Centre for Alzheimer´s and Dementia Cares´s (CREA) of Imserso and the Scientific Summit (September 20-22) organized by the Center of Research in Neurological Diseases (CIEN) Foundation and the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED). Each thematic area is aimed to a different audience and has its own program to give us a more complete overview of Alzheimer´s Disease in order to advance in the understanding of this neurodegenerative disease:
The Social and Health Care Research.
Innovative experiences related to the use of non-pharmacological therapies and people-centered care will be shown in order to promote socio-health research and normalize the daily lives of people with dementia and their families.
This forum, which will host the most relevant experts and researchers at an international level, seeks from a scientific approach to respond to both professionals and caregivers on how to improve the quality of life of people living with Alzheimer's disease.
As in previous years, the CRE of Alzheimer's together with the Reina Sofia Foundation, through these meetings, aims to bring society closer to the advances of research in the fight against Alzheimer's disease and, above all, to raise the evident need to advance in the search for global solutions and responses.
The Scientific Summit or Global Summit on Neurodegenerative Diseases focuses on main research advances in neurodegenerative disorders, particularly Alzheimer´s, Parkinson´s and Huntington´s diseases. This annual meeting is annually celebrated under the denomination of International Congress on Innovation and Research in Neurodegenerative Diseases (CIIIEN), which is organized since 2013 by the Queen Sofia Foundation, the Center of Research in Neurological Diseases (CIEN) and the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) and offers a forum to discuss a range of areas of interest related to basic, clinical and translational aspects of the research on the neurodegenerative diseases. More than 400 researchers from several countries will attended this Global Summit.
We look forward to welcoming you in Lisbon, Portugal.
Parkinson's disease (PD) was first described by the English doctor James Parkinson in 1871. It is a chronic and progressive neurological pathology which primarily affects body movements. PD is the second most common neurodegenerative condition after …READ MORE
A Cimeira Mundial de Alzheimer vai realizar-se entre 18 e 22 de Setembro de 2017 em Lisboa, na Fundação Champalimaud, com o apoio da Fundação Rainha Sofia (Espanha). Esta importante cimeira sobre a Doença de Alzheimer assentará em dois pilares fundam…READ MORE
Alzheimer's disease (AD), which was first described in 1906, is the most common form of dementia among the elderly. Dementias are related to brain damage caused by certain diseases, including AD, a pathology that seriously affects a person's ability …READ MORE
The form has been sent successfully.